You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial

Article metrics

Article menu

Download PDFPDF

Oral Plenary
Plenary V
IGCS20_1207
18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to April 2024

AbstractFullPdf
Nov 202051013
Dec 202063010
Jan 2021170042
Feb 2021119045
Mar 2021140038
Apr 2021128039
May 202159039
Jun 20212037
Jul 20210029
Aug 20210035
Sep 20210032
Oct 2021163046
Nov 2021241065
Dec 2021206040
Jan 2022102014
Feb 202262017
Mar 2022126017
Apr 20227405
May 202280017
Jun 2022126019
Jul 202278012
Aug 2022110023
Sep 2022110015
Oct 2022120013
Nov 2022112011
Dec 20223809
Jan 20238809
Feb 2023116016
Mar 20235403
Apr 202332014
May 20236209
Jun 20236609
Jul 20234407
Aug 20234004
Sep 20234609
Oct 20233207
Nov 20234407
Dec 20235505
Jan 20241603
Feb 202428011
Mar 202424017
Apr 20242808
Total32550820